Augmedix, Inc. (NASDAQ:AUGX) has upsized its public offering to 6.25 million shares at $4.00 per share, up from the previously announced 5.5 million shares. The offering is expected to raise $25 million before fees and expenses. The company granted underwriters an option to purchase an additional 937,500 shares. The proceeds will fund sales and marketing, R&D, general and administrative costs, working capital, capital expenditures, and general corporate purposes, with a focus on accelerating its product roadmap for emergency department care solutions. The offering is set to close around November 20, 2023.